Related Experiment Video
Updated: Jun 13, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
MerlinS13 phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features
Charlotte D Eaton1,2,3, Lauro Avalos2,4, S John Liu1,2,3
1Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Abstract:
Meningiomas are associated with inactivation of NF2/Merlin, but approximately one-third of meningiomas with favorable clinical outcomes retain Merlin expression. Biochemical mechanisms underlying Merlin-intact meningioma growth are incompletely understood, and non-invasive biomarkers that may be used to guide treatment de-escalation or imaging surveillance are lacking. Here, we use single-cell RNA sequencing, proximity-labeling proteomic mass spectrometry, mechanistic and functional approaches, and magnetic resonance imaging (MRI) across meningioma xenografts and patients to define biochemical mechanisms and an imaging biomarker that underlie Merlin-intact meningiomas. We find Merlin serine 13 (S13) dephosphorylation drives meningioma Wnt signaling and tumor growth by attenuating inhibitory interactions with β-catenin and activating the Wnt pathway. MRI analyses show Merlin-intact meningiomas with S13 phosphorylation and favorable clinical outcomes are associated with high apparent diffusion coefficient (ADC). These results define mechanisms underlying a potential imaging biomarker that could be used to guide treatment de-escalation or imaging surveillance for patients with Merlin-intact meningiomas.
Insights
Merlin-intact meningiomas grow due to Merlin serine 13 dephosphorylation activating Wnt signaling. High apparent diffusion coefficient (ADC) on MRI may indicate favorable outcomes for these tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biochemistry
Background:
- Meningiomas often involve NF2/Merlin inactivation, but some retain Merlin expression.
- Mechanisms of Merlin-intact meningioma growth and non-invasive biomarkers are poorly understood.
- Current understanding lacks biomarkers for guiding treatment de-escalation or imaging surveillance in Merlin-intact meningiomas.
Purpose of the Study:
- To elucidate biochemical mechanisms driving Merlin-intact meningioma growth.
- To identify an imaging biomarker for Merlin-intact meningiomas.
- To correlate molecular findings with clinical outcomes and imaging characteristics.
Main Methods:
- Single-cell RNA sequencing and proximity-labeling proteomic mass spectrometry.
- Mechanistic and functional studies in xenografts and patient samples.
- Magnetic resonance imaging (MRI) analysis, including apparent diffusion coefficient (ADC) measurements.
Main Results:
- Merlin serine 13 (S13) dephosphorylation promotes Wnt signaling and meningioma growth by affecting β-catenin interactions.
- Merlin-intact meningiomas with S13 phosphorylation correlate with favorable clinical outcomes.
- High ADC values on MRI are associated with Merlin-intact meningiomas exhibiting S13 phosphorylation and favorable outcomes.
Conclusions:
- Merlin S13 dephosphorylation is a key driver of Wnt signaling in Merlin-intact meningiomas.
- Apparent diffusion coefficient (ADC) on MRI may serve as a non-invasive biomarker for Merlin-intact meningiomas.
- These findings could guide treatment de-escalation and imaging surveillance strategies for specific meningioma subtypes.
Related Concept Videos
Magnetic Resonance Imaging
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Canonical Wnt Signaling Pathway
Abnormal Proliferation

